You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Patent: 7,686,786


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,686,786
Title:Dial-down mechanism for wind-up pen
Abstract: The present invention relates to a dial-down mechanism for an injection device comprising a torsion spring for assisting injection of a dose of medicament from the injection device, the dial-down mechanism comprising dial-up cam arranged to receive and engage with a dial-up key, wherein the dial-up cam and the dial-up key are adapted to, upon rotation of a dose setting member in a first direction, cooperate to strain the torsion spring of the injection device, and a dial-down cam arranged to receive and engage with a dial-down key, wherein the dial-down cam and the dial-down key are adapted to, upon rotation of the dose setting member in a second direction, cooperate to release the torsion spring of the injection device, the second rotation direction being opposite to the first rotation direction.
Inventor(s): Moller; Claus Schmidt (Fredensborg, DK), Enggaard; Christian Peter (Vejby, DK), Radmer; Bo (Hillerod, DK), Markussen; Tom Hede (Bagsv.ae butted.rd, DK)
Assignee: Novo Nordiks A/S (Bagsvaerd, DK)
Application Number:11/665,486
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,686,786
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 7,686,786

Introduction

United States Patent 7,686,786, like any other patent, is a complex document that requires a thorough analysis to understand its implications, strengths, and weaknesses within the broader patent landscape. This analysis will delve into the key aspects of the patent, including its claims, the examination process, and its position within the competitive landscape.

Understanding the Patent Claims

The claims of a patent are its most critical component, as they define the scope of the invention and what is protected under the patent. For U.S. Patent 7,686,786, it is essential to analyze each claim to determine its novelty, non-obviousness, and utility, which are the conditions for patentability[3].

Claim Construction

Claim construction involves interpreting the language of the claims to understand their scope. This process is crucial for determining what is covered by the patent and what is not. The claims must be clear and definite to avoid ambiguity and potential litigation issues.

Novelty and Non-Obviousness

The patent office examines whether the claims are novel and non-obvious in light of prior art. Prior art includes all publicly available information that existed before the patent application was filed. The examiner must determine whether the claims overcome the technical features disclosed in the prior art, ensuring that the invention is new and not an obvious extension of existing knowledge[3].

The Examination Process

The examination process for U.S. Patent 7,686,786 involves a detailed back-and-forth between the patent applicant and the patent office examiner. This process, known as patent prosecution, is documented in the patent's file wrapper.

File Wrapper Analysis

The file wrapper contains all the correspondence between the applicant and the examiner, including arguments made about the patentability of the claims. Analyzing the file wrapper provides insight into the challenges faced during the examination process and how they were overcome. It includes details such as prior art citations, examiner search strategies, and the applicant's responses to office actions[3].

Competitive Intelligence and Patent Landscape

Understanding the competitive landscape is vital for assessing the value and impact of a patent. This involves analyzing the technology and patent landscape to see how U.S. Patent 7,686,786 fits into the broader scheme.

Technology and Patent Landscape Analysis

Reviewing the patent landscape involves looking at similar innovations and how they relate to the patented invention. This analysis helps in identifying market trends, R&D activities, and business development strategies of competitors. It also provides insight into potential licensing opportunities or areas where the patent could be challenged[3].

Challenges and Controversies

Patents, especially those in highly competitive fields, often face challenges and controversies.

Terminal Disclaimers and Patent Thickets

In some cases, patents may be part of a larger strategy involving terminal disclaimers and patent thickets. Terminal disclaimers link the enforceability of patents together, which can be a strategy to extend the life of a patent portfolio. However, this can also lead to issues of duplicative patents and delayed access to generic or biosimilar products[1].

Inter Partes Review (IPR) and Post-Grant Review (PGR)

The Patent Trial and Appeal Board (PTAB) provides mechanisms like IPR and PGR to challenge the validity of patents. These procedures are faster and less expensive than federal court litigation and use a lower standard of proof. This can be a significant factor in the patent's enforceability and validity[2].

Subject Matter Eligibility

For patents involving advanced technologies like AI, subject matter eligibility is a critical issue.

AI Inventions and Subject Matter Eligibility

The USPTO's 2024 Guidance Update clarifies that AI inventions can be patentable, but they must meet specific criteria. The key inquiry lies in demonstrating that the claims are directed to a specific, concrete technological advancement or solution to a technical problem. This involves a practical applicability analysis under Step 2A, Prong Two of the subject matter eligibility framework[5].

Practical Implications and Strategies

For a patent like U.S. Patent 7,686,786, several practical implications and strategies come into play.

Patent Prosecution Strategies

Patent applicants can use various strategies to ensure their invention is adequately protected. This includes traversing obviousness-type double patenting rejections, using reissuance to ensure the validity of parent patents, and optimizing claims to avoid terminal disclaimers[1].

Licensing and Enforcement

The patent's value lies in its ability to be enforced and potentially licensed. Understanding the competitive landscape and the strength of the patent claims is crucial for negotiating licensing agreements or defending against infringement claims.

Case Studies and Examples

Real-world examples can provide valuable insights into how patents like U.S. Patent 7,686,786 are used and challenged.

Example: IMBRUVICA Patents

The case of IMBRUVICA, a drug manufactured by Johnson and Johnson, illustrates the complexity of patent thickets and terminal disclaimers. With 41 patents listed, 75% of which are terminally disclaimed, this example highlights the strategic use of patents to extend market exclusivity and the potential challenges this poses for generic or biosimilar products[1].

Regulatory and Legislative Framework

The regulatory and legislative framework governing patents is constantly evolving.

The Leahy-Smith America Invents Act (AIA)

The AIA introduced significant changes to U.S. patent law, including the creation of PTAB and the procedures for IPR and PGR. These changes aim to improve patent quality and provide a more efficient system for challenging patents[2].

USPTO Proposals and Guidelines

The USPTO regularly issues proposals and guidelines to improve the patent examination process. For example, the proposed rules on restrictions on claims and continuation applications aim to balance the need for innovation with the need to prevent abusive patent practices[1].

Key Takeaways

  • Claims Analysis: The claims of a patent are its most critical component and must be analyzed for novelty, non-obviousness, and utility.
  • Examination Process: The file wrapper provides valuable insight into the patent prosecution process and the challenges faced during examination.
  • Competitive Intelligence: Analyzing the patent landscape is essential for understanding market trends and competitor strategies.
  • Challenges and Controversies: Patents can face challenges through IPR, PGR, and issues related to terminal disclaimers and patent thickets.
  • Subject Matter Eligibility: AI inventions must meet specific criteria to be considered patentable, focusing on practical applicability and technological advancements.
  • Practical Implications: Effective patent prosecution strategies, licensing, and enforcement are crucial for maximizing the value of a patent.

FAQs

Q: What is the significance of the file wrapper in patent analysis? A: The file wrapper contains all the correspondence between the patent applicant and the examiner, providing insight into the patentability arguments and the challenges faced during the examination process[3].

Q: How do terminal disclaimers affect patent enforceability? A: Terminal disclaimers link the enforceability of patents together, which can extend the life of a patent portfolio but also lead to issues of duplicative patents and delayed access to generic or biosimilar products[1].

Q: What is the role of PTAB in challenging patent validity? A: PTAB provides mechanisms like IPR and PGR to challenge the validity of patents, which are faster and less expensive than federal court litigation and use a lower standard of proof[2].

Q: How does the USPTO's 2024 Guidance Update impact AI inventions? A: The guidance update clarifies that AI inventions can be patentable if they meet specific criteria, focusing on practical applicability and technological advancements under Step 2A, Prong Two of the subject matter eligibility framework[5].

Q: What are the practical implications of patent thickets for pharmaceutical products? A: Patent thickets can delay access to generic or biosimilar products by extending the life of a patent portfolio, as seen in the case of IMBRUVICA[1].

Sources

  1. Letterhead DC Office - Regulations.gov: "Our patents reflect important innovative and inventive steps that the United States Patent and Trademark Office agreed merit protection."
  2. The Patent Trial and Appeal Board and Inter Partes Review: "Congressional Research Service."
  3. Patent file wrappers as a tool for competitive intelligence: "IP Checkups."
  4. The Patent & Trademark Office Speaks - Association of Corporate Counsel: "Managing the Consequent Problems for Application Pendency and Maintaining and Improving Examination Quality."
  5. The Importance of Prong Two of Step 2A for AI Inventions - Baker Botts: "Under the direction of President Biden’s executive order on artificial intelligence (AI)."

More… ↓

⤷  Subscribe

Details for Patent 7,686,786

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 June 07, 2000 7,686,786 2024-10-21
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 January 19, 2001 7,686,786 2024-10-21
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 April 23, 2004 7,686,786 2024-10-21
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 October 31, 2013 7,686,786 2024-10-21
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.